4//SEC Filing
Adawi Kamal 4
Accession 0001274737-23-000007
CIK 0001274737other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:05 PM ET
Size
4.8 KB
Accession
0001274737-23-000007
Insider Transaction Report
Form 4
EXAGEN INC.XGN
Adawi Kamal
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-08$2.69/sh−5,821$15,671→ 91,938 total
Footnotes (1)
- [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001788393
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:05 PM ET
- Size
- 4.8 KB